Only 28% fully adherent: in hypopituitarism, more medicines go with lower adherence to hormone replacement

Only 28 percent adherence to hormone replacement in hypopituitarism — news card

Written by

in

Priority: normal · Status: published

Date: 2026-11-05 (Archives of Endocrinology and Metabolism, online ahead of print)

Source: Archives of Endocrinology and Metabolism — PubMed — https://pubmed.ncbi.nlm.nih.gov/43024765/

What happened?

A study by researchers from Brazil (Federal University of Paraná) and Sweden (University of Gothenburg, Sahlgrenska) was published online in Archives of Endocrinology and Metabolism on 5 November 2026.

It examined how regularly adults with hypopituitarism take their hormone replacement and what affects adherence.

What is this about? (short)

In hypopituitarism the pituitary gland does not make enough of one or more hormones. Patients often take several medicines for life, such as glucocorticoids (cortisone-type), thyroid hormone and sex hormones.

“Adherence” means taking medicines as your doctor advised — on time and without missed doses.

Study summary

126 adults followed at a tertiary centre in Brazil were assessed. Adherence was measured with two questionnaires (the Morisky-Green test and a modified Brief Medication Questionnaire).

Good adherence was seen in only 28% (Morisky-Green) and 27% (Brief Medication Questionnaire); moderate or low adherence predominated.

Polypharmacy (many medicines) was present in 61.1% and was linked to lower adherence. Female sex, use of psychiatric medicines, each additional medicine and not being on glucocorticoid replacement were independently associated with non-adherence.

No links were found with age, education, income, disease duration, cause or healthcare access. The authors call for research into patient-centred education and simpler regimens. As a cross-sectional study, it cannot show cause and effect.

Who is it for?

People with hypopituitarism who take several hormone medicines; also people with Addison’s who take many medicines because of multiple hormone deficiencies, such as in APS-2.

Endocrinologists, pharmacists and carers.

Access / country context

The study was done at a single centre in Brazil; results may not transfer directly to other countries. But the finding that many medicines make adherence harder is widely familiar.

What it means for patients in Türkiye

If you take several hormone medicines, phone reminders, a weekly pill organiser or a written medicine list can make it easier to keep track.

If the number of medicines is a burden, talk to your doctor and pharmacist; only your doctor can decide on changes to your regimen. This article gives no dose information.

Warning: This is a news summary, not dose or treatment advice. Ask your endocrinologist.

Prepared by: Asistan · 16 November 2026. Source: Archives of Endocrinology and Metabolism article abstract (PubMed).

Medical disclaimer: Information on this site is prepared by a patient community for general awareness; for diagnosis, treatment or dose changes always consult your own doctor (endocrinologist). In an emergency call your local emergency number.